Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.
暂无分享,去创建一个
Dae-Duk Kim | Dae-Duk Kim | C. Shim | Min-Koo Choi | F. Cui | Suk-Jae Chung | Chang-Koo Shim | Fu-De Cui | Tao Yang | Jei-Won Cho | Tao Yang | Min-Koo Choi | Jeiwon Cho | S. Chung | Min‐Koo Choi
[1] J. Beijnen,et al. Preclinical pharmacokinetics of paclitaxel and docetaxel. , 1998, Anti-cancer drugs.
[2] P. Artursson,et al. Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. , 1990, Journal of pharmaceutical sciences.
[3] R. Straubinger,et al. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. , 1996, Cancer letters.
[4] C. Yong,et al. Pharmacokinetics of a new antitumor 3-arylisoquinoline derivative, CWJ-a-5. , 2001, International journal of pharmaceutics.
[5] Chong-Kook Kim,et al. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. , 2005, Biomaterials.
[6] Can Zhang,et al. Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. , 2004, Colloids and surfaces. B, Biointerfaces.
[7] V. Torchilin,et al. Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .
[8] M. Luscombe,et al. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. , 1987, British Journal of Cancer.
[9] J. Beijnen,et al. Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography. , 1995, Journal of chromatography. B, Biomedical applications.
[10] D. Aggarwal,et al. Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.
[11] J. Crowe,et al. Preservation of freeze-dried liposomes by trehalose. , 1985, Archives of biochemistry and biophysics.
[12] J. Zhang,et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] J. Au,et al. Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching. , 1995, Journal of chromatography. B, Biomedical applications.
[14] I. Chu,et al. Liposomal delivery system for taxol , 1997 .
[15] D. Brocks,et al. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. , 2005, Biomaterials.
[16] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[17] Chen Lin,et al. Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin , 2006, Cancer Chemotherapy and Pharmacology.
[18] R. Mumper,et al. Paclitaxel nanoparticles for the potential treatment of brain tumors. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[19] Dae-Duk Kim,et al. Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability , 2007, Drug delivery.
[20] F. Dosio,et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[21] T. Allen,et al. Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. , 2005, Biochimica et biophysica acta.
[22] B. Leyland-Jones,et al. Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Perez-soler,et al. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size , 1996, Cancer Chemotherapy and Pharmacology.
[24] M. Bally,et al. Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. , 1985, Biochimica et biophysica acta.
[25] R. Donehower,et al. Drug therapy : paclitaxel (Taxol) , 1995 .
[26] F. Dosio,et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[27] W. Hinrichs,et al. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. , 2006, International journal of pharmaceutics.
[28] N. Oku,et al. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. , 2004, Journal of controlled release : official journal of the Controlled Release Society.